Profile
Kevin N.
Heller worked as a Senior Medical Director at AstraZeneca PLC from 2013 to 2015.
He then worked as VP & Head-Antibody Clinical Development at Incyte Corp.
from 2015 to 2018.
From 2018 to 2020, he served as Chief Medical Officer at NextCure, Inc. In 2021, he worked as Executive Vice President-Research & Development at Jasper Therapeutics, Inc. Dr. Heller holds a doctorate degree from George Washington University and an undergraduate degree from Yale University.
Former positions of Kevin N. Heller
| Companies | Position | End |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-03-16 |
| NEXTCURE, INC. | Chief Tech/Sci/R&D Officer | 2020-08-03 |
| INCYTE CORPORATION | Corporate Officer/Principal | 2018-03-31 |
| ASTRAZENECA PLC | Chief Tech/Sci/R&D Officer | 2015-04-30 |
Training of Kevin N. Heller
| George Washington University | Doctorate Degree |
| Yale University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| NEXTCURE, INC. | Health Technology |
| JASPER THERAPEUTICS, INC. | Finance |
- Stock Market
- Insiders
- Kevin N. Heller
